haloperidol has been researched along with Hepatolenticular Degeneration in 6 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acquired hepatocerebral degeneration (AHD) and hepatolenticular degeneration can have similar clinical presentations, but when a chronic liver disease and atypical motor findings coexist, the distinction between AHD and hepatic encephalopathy (HE) can be even more complicated." | 1.37 | Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease. ( Américo, MF; Caramori, CA; Romeiro, FG; Santos, AC; Schelp, AO; Silva, GF; Yamashiro, FS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozcan, O | 1 |
| Selimoğlu, MA | 1 |
| Romeiro, FG | 1 |
| Américo, MF | 1 |
| Yamashiro, FS | 1 |
| Caramori, CA | 1 |
| Schelp, AO | 1 |
| Santos, AC | 1 |
| Silva, GF | 1 |
| Jukić, I | 1 |
| Titlić, M | 1 |
| Tonkić, A | 1 |
| Dodig, G | 1 |
| Rogosić, V | 1 |
| Ott, J | 1 |
| Müller, E | 1 |
| Heidrich, R | 1 |
| Bruun, RD | 1 |
| Shapiro, AK | 1 |
| Bhaskar, PA | 1 |
| Jagannathan, K | 1 |
6 other studies available for haloperidol and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Self-injury behavior in an adolescent with Wilson's disease.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain; Citalopram; Diagn | 2009 |
Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease.
Topics: Anti-Dyskinesia Agents; Diagnosis, Differential; Disease Progression; Female; Haloperidol; Hepatic E | 2011 |
Psychosis and Wilson's disease: a case report.
Topics: Acute Disease; Adult; Antipsychotic Agents; Athetosis; Chelating Agents; Chorea; Diagnosis, Differen | 2006 |
[Differential diagnosis of acute extrapyramidal motor disorders in children. A case study].
Topics: Acute Disease; Adolescent; Basal Ganglia Diseases; Diagnosis, Differential; Female; Haloperidol; Hep | 1974 |
Differential diagnosis of Gilles de la Tourette's syndrome.
Topics: Adolescent; Adult; Child; Child, Preschool; Diagnosis, Differential; Diffuse Cerebral Sclerosis of S | 1972 |
Haloperidol in the treatment of dyskinesias.
Topics: Adolescent; Adult; Child; Chorea; Diencephalon; Female; Haloperidol; Hepatolenticular Degeneration; | 1974 |